60 Degrees Pharmaceuticals Inc (SXTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -7,956 | -3,814 | -6,178 | -4,260 |
| Depreciation Amortization | 3,640 | 1,832 | 1,244 | 676 |
| Accounts receivable | -255 | -185 | 100 | 713 |
| Other Working Capital | 193 | 405 | 3,370 | 2,897 |
| Other Operating Activity | -1,269 | -2,781 | 454 | -675 |
| Operating Cash Flow | $-5,648 | $-4,543 | $-1,010 | $-649 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -1,708 | N/A | N/A | N/A |
| PPE Investments | -156 | -98 | -33 | -35 |
| Purchase Sale Intangibles | -25 | -18 | -27 | N/A |
| Other Investing Activity | -25 | -18 | -27 | 0 |
| Investing Cash Flow | $-1,889 | $-116 | $-60 | $-35 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | 900 | 1,290 | 683 |
| Debt Repayment | N/A | -1,861 | N/A | -72 |
| Common Stock Issued | 5,324 | 7,436 | N/A | N/A |
| Other Financing Activity | 1,730 | 0 | -69 | 0 |
| Financing Cash Flow | $7,054 | $6,475 | $1,222 | $611 |
| Exchange Rate Effect | 1 | 62 | -2 | -3 |
| Beginning Cash Position | 2,143 | 265 | 115 | 192 |
| End Cash Position | 1,659 | 2,143 | 265 | 115 |
| Net Cash Flow | $-483 | $1,878 | $150 | $-76 |
| Free Cash Flow | ||||
| Operating Cash Flow | -5,648 | -4,543 | -1,010 | -649 |
| Capital Expenditure | -156 | -98 | -33 | -35 |
| Free Cash Flow | -5,804 | -4,641 | -1,043 | -685 |